Behaviour of cefmenoxime towards beta-lactamases

Area of Science:

• Microbiology
• Pharmacology
• Biochemistry

Background:

• Beta-lactamase enzymes from Gram-negative bacteria are a significant challenge in treating bacterial infections.
• Understanding antibiotic interactions with these enzymes is crucial for developing effective treatments.
• Methoxy-imino-amino-2-thiazol cephalosporins represent a class of antibiotics with potential activity against resistant bacteria.

Purpose of the Study:

• To compare the interactions of the novel cephalosporin, cefmenoxime, with various beta-lactamases.
• To evaluate cefmenoxime's affinity for specific enzymes, including penicillinase TEM-1 and cephalosporinases.
• To assess cefmenoxime's susceptibility in comparison to established antibiotics like cefotaxime.

Main Methods:

• Utilized well-characterized beta-lactamases isolated from Gram-negative bacteria.
• Employed on-line computerized microacidimetry to determine the inhibitory constants (Ki values) of antibiotics.
• Conducted Masuda's double disc technique to assess relative susceptibility.

Main Results:

• Cefmenoxime demonstrated poor interaction (low Vm, poor affinity) with penicillinase TEM-1.
• Cefmenoxime exhibited high affinity for cephalosporinases, similar to cefotaxime and lamoxactam.
• Both cefmenoxime and cefotaxime showed relative susceptibility in the double disc assay.

Conclusions:

• Cefmenoxime displays differential activity against Gram-negative bacterial beta-lactamases.
• Its high affinity for cephalosporinases suggests potential efficacy against certain resistant strains.
• Further investigation into cefmenoxime's clinical utility against beta-lactamase-producing bacteria is warranted.